ScoreWhy is Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of -1.43% and Operating profit at -7.15% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 4.72% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -1.43% and Operating profit at -7.15% over the last 5 years
3
The company has declared Negative results for the last 4 consecutive quarters
- INTEREST(9M) At CNY 0.28 MM has Grown at 219.63%
- OPERATING CASH FLOW(Y) Lowest at CNY 59.65 MM
- DEBT-EQUITY RATIO (HY) Highest at -27.45 %
4
With ROE of 4.27%, it has a fair valuation with a 0.00 Price to Book Value
- Over the past year, while the stock has generated a return of 16.80%, its profits have fallen by -10.9%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd.
-100.0%
0.92
32.77%
China Shanghai Composite
24.8%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-1.43%
EBIT Growth (5y)
-7.15%
EBIT to Interest (avg)
34.61
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.26
Tax Ratio
13.74%
Dividend Payout Ratio
50.26%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.15%
ROE (avg)
4.72%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
EV to EBIT
-6.88
EV to EBITDA
-4.03
EV to Capital Employed
-0.38
EV to Sales
-1.00
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
4.27%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
INVENTORY TURNOVER RATIO(HY)
Highest at 3.02%
RAW MATERIAL COST(Y)
Fallen by 1.12% (YoY
NET SALES(Q)
Highest at CNY 74.12 MM
OPERATING PROFIT(Q)
Highest at CNY 24.09 MM
OPERATING PROFIT MARGIN(Q)
Highest at 32.5 %
PRE-TAX PROFIT(Q)
At CNY 17.97 MM has Grown at 56.18%
NET PROFIT(Q)
Highest at CNY 16.58 MM
EPS(Q)
Highest at CNY 0.22
-12What is not working for the Company
INTEREST(9M)
At CNY 0.28 MM has Grown at 219.63%
OPERATING CASH FLOW(Y)
Lowest at CNY 59.65 MM
DEBT-EQUITY RATIO
(HY)
Highest at -27.45 %
Here's what is working for Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd.
Inventory Turnover Ratio
Highest at 3.02% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Net Sales
Highest at CNY 74.12 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Net Sales
At CNY 74.12 MM has Grown at 21.78%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 24.09 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at 32.5 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CNY 17.97 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Pre-Tax Profit
At CNY 17.97 MM has Grown at 56.18%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 16.58 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Net Profit
At CNY 16.58 MM has Grown at 62.77%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.22
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Raw Material Cost
Fallen by 1.12% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Jilin Province Xidian Pharmaceutical Sci-Tech Dev Co., Ltd.
Interest
At CNY 0.27 MM has Grown at 553.35%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Debt-Equity Ratio
Highest at -27.45 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Operating Cash Flow
Lowest at CNY 59.65 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
